INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2019

A meta-analysis found curcumin improved cognitive scores in older adults, while treated Alzheimer's patients showed a trend to do worse than placebo on the MMSE.

A systematic review and meta-analysis of six randomized controlled trials totaling 289 subjects evaluated curcumin for cognitive function. For older adults, curcumin improved cognitive function scores (SMD = 0.33, 95% CI [0.05, 0.62]; p = 0.02), with adverse events OR = 5.59 (95% CI [0.96, 36.80]; p = 0.05) and depression measures SMD = -0.29 (95% CI [0.64, 0.05]; p = 0.09). In Alzheimer's disease patients, cognition scores indicated a trend for treated subjects to do worse than placebo on the Mini-Mental State Examination (SMD = -0.90, 95% CI [1.48, -0.32]; p = 0.002). Limitations noted were a small number of studies, preventing funnel plot or sensitivity analysis, and insufficient data for schizophrenia outcomes.

Study type
Systematic review and meta-analysis of randomized controlled trials
Who was studied
289 subjects across 6 randomized controlled trials (including older adults and Alzheimer's disease patients)
What was measured
Cognitive function, adverse events, depression measures

THE PAPER

Curcumin intervention for cognitive function in different types of people: A systematic review and meta-analysis.

Zhu LN, Mei X, Zhang ZG, Xie YP, Lang F. Phytother Res, 2019.

PubMed 30575152 ↗DOI 10.1002/ptr.6257 ↗

Brain & moodHealthy aging & longevity

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.